Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD) and Brainstorm Cell Therapeutics (BCLI)

TipRanksDec 15 23:50 · Ratings

BrainStorm Strengthens Exosome Patent Portfolio: Receives Notice of Allowance for U.S. Patent Covering Its Platform Technology

PR NewswireDec 3 20:00

BrainStorm Cell Therapeutics to Host KOL Webinar on Current Developments in the Treatment of Amyotrophic Lateral Sclerosis (ALS) on December 11, 2024

PR NewswireDec 2 20:00

Brainstorm Cell Q3 2024 GAAP EPS $(0.51) Beats $(0.57) Estimate

BenzingaNov 15 06:23

Brainstorm Cell Therapeutics | 8-K: BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update

SECNov 15 05:51

Brainstorm Cell Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 15 05:46 · Announcements